Treatments for metastatic melanoma: Synthesis of evidence from randomized trials-Reference-Cited by-同舟云学术

Treatments for metastatic melanoma: Synthesis of evidence from randomized trials

Published:2007-12 Issue:8 Volume:33 Page:665-680
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Lui Philip,Cashin Richard,Machado Márcio,Hemels Michiel,Corey-Lisle Patricia K.,Einarson Thomas R.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference68 articles.

1. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma;Lens;Brit J Dermatol,2004

2. Surveillance Research Program, Cancer Statistics Branch, Surveillance, Epidemiology, and End Results (SEER) Program. Washington: National Cancer Institute; 2005.

3. Prognostic factors in 1521 melanoma patients with distant metastases;Barth;J Am Coll Surg,1995

4. Prognostic factors for survival of patients treated systemically for disseminated melanoma;Eton;J Clin Oncol,1998

5. Systemic treatments for metastatic cutaneous melanoma;Crosby;Cochrane Database Syst Rev,2000

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DACARBAZINE INITIATES SIRT1-INDEPENDENT OVEREXPRESSION OF ANTI-APOPTOTIC BCL2 IN MELANOMA CELLS IN VIVO;Molekulyarnaya Meditsina (Molecular medicine);2024-08-02

2. Investigating Therapeutic Efficacy of Dacarbazine and Temozolomide, Alone and in Combination with BRAF(V600E) siRNA in A375 Human Melanoma Cell Line;2024-04-03

3. Pathology and Molecular Biology of Melanoma;Current Issues in Molecular Biology;2023-06-30

4. The Distribution of B16 Melanoma Cells in Cell-Cycle Phases under the Influence of Dacarbazine;Cell and Tissue Biology;2023-04

5. Safety and efficacy of nivolumab compared with other regimens in patients with melanoma: A network meta-analysis;Medicine;2022-09-02